A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 952
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CIC
Long Form : circulating immune complexes
No. Year Title Co-occurring Abbreviation
2020 Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial. Ab, BD, ES, HAM-D, MD, PAG, RCT
2020 Efficacy assessment of the scheme for prevention of herpesvirus infection manifestations in the oral cavity of patients with herpes-associated generalized moderate severity periodontitis. BMM, CHGP, HVI
2020 Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. CT, DAA, IC, PDA, TAA
2020 Vaccination with LetiFend reduces circulating immune complexes in dogs experimentally infected with L. infantum. CanL, VL
2019 Analysis of the level of selected parameters of inflammation, circulating immune complexes, and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases. COPD, CRP, GOLD
2019 Circulating immune complexes levels correlate with the progression of canine leishmaniosis in naturally infected dogs. CanL
2019 Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database. aHUS, AKI, FH, GEE, LVH, PEX, SRBC
2019 Depletion of interfering IgG and IgM is critical to determine the role of IgE in pegvaliase-associated hypersensitivity. ADA, HAEs, Phe, PKU
2019 Formation and glomerular deposition of immune complexes in mice administered bovine serum albumin: Evaluation of dose, frequency, and biomarkers. ADA, BSA, cCIC, IC
10  2019 Role of p300 in the pathogenesis of Henoch-Schonlein purpura nephritis and as a new target of glucocorticoid therapy in mice. AP, GR, HSPN, TGF
11  2019 The Immunological Plasmodium falciparum Malaria Characteristics of Children in Tajikistan Republic. ---
12  2018 Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. ADA, HAE, Ig, PEG, Phe, PKU
13  2018 Circulating Immune Complexes and Heat Shock Protein 70 in the Sera of Patients with Sudden Sensorineural Hearing Loss. ENT, HSP70, SSHL
14  2018 Otolaryngological symptoms in patients treated for tick-borne diseases. TBE
15  2018 Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome. APS, B2GPI, LR
16  2018 The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus. IL-6, OR, SLE
17  2017 Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing Ehrlich solid carcinoma. CAT, CEP, CTL, Mph, NK
18  2017 [The immunological characteristics and enzymatic activity of lymphocytes from the peripheral blood of the children presenting with pharyngeal tonsillar hypertrophy]. PTH
19  2016 Circulating immune complexes of calves with bronchopneumonia modulate the function of peripheral blood leukocytes: In vitro evaluation. MNCs
20  2016 Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus. aPL, NP, SLE
21  2016 Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2'-O-Methoxyethyl Modified Antisense Oligonucleotide. 2'-MOE, ASO, i.v, s.c
22  2016 Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseases. AMIDA, LIPS, MS, NAPPA, PhIP-Seq, SELDI-TOF, SEREX, SERPA
23  2016 Primary psychosis and Borna disease virus infection in Lithuania: a case control study. BDV, BPRS
24  2016 Risk factors of uveitis in ankylosing spondylitis: An observational study. AS, ASO, CRP, ESR
25  2016 SEC Based Method for Size Determination of Immune Complexes of Therapeutic Antibodies in Animal Matrix. ADA, mAbs
26  2016 [Antibodies against modified low-density lipoproteins and their complexes in blood of patients with various manifestations of atherosclerosis]. Abs, acetyl-LDL, ELISA, hypochlorite-LDL, MDA, MDA-LDL
27  2016 [Investigation of autoimmunity markers during interferon alpha therapy of chronic hepatitis B and C - twenty years of experience]. AMA, ANA, IFN, RF, SMA
28  2016 [The influence of endogenous intoxication on the clinical picture of various forms of acute stenosinglaryngotracheitis in the children]. ---
29  2015 Cytotoxic activity of immune cells following administration of xenogeneic cancer vaccine in mice with melanoma B-16. CTA, PM, XCV
30  2015 Detection of circulating immune complexes of human IgA and beta 2 glycoprotein I in patients with antiphospholipid syndrome symptomatology. aPL, APS, B2GPI
31  2015 Health care professionals at risk of infection with Borna disease virus - evidence from a large hospital in China (Chongqing). BDV, CQMU, MDD
32  2015 How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy. ---
34  2015 Status of circulating immune complexes, IL8 titers and cryoglobulins in patients with dengue infection. ROC
35  2015 The Presence of Some Humoral Immunologic Indicators and Clinical Manifestations in Cryoglobulin Positive Heroin Addicts without Evidence of Hepatitis Virus Infection. CG, CN, CP, RF
37  2014 Advances in mechanisms of systemic lupus erythematosus. NETs, pDCs, SLE
38  2014 Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro. ---
39  2014 Borna disease virus (BDV) infection in psychiatric patients and healthy controls in Iran. Ab, BDV, EIA
40  2014 Clinical significance of the antinuclear antibodies in chronic viral hepatitis B in children. ANA
41  2014 Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients. CRP, DAS28, ELISA, L-CR1, PEG, RA
42  2014 Research on the occurrence of Mycobacterium tuberculosis antigens in the circulating immune complexes, isolated from serum of patients with tuberculosis. ---
43  2014 Serum protein profiles, circulating immune complexes and proteinuria in dogs naturally infected with Anaplasma phagocytophilum. ---
44  2014 The Relations Between Immunity, Oxidative Stress and Inflammation Markers, in Childhood Obesity. ASMA, CRP, GPx, SOD
46  2014 [Characteristic of circulating immune complexes in the blood of children with asthma]. ---
47  2014 [Effect of immunomodulatory therapy on circulatory immune complexes in patients with recurrent depressive disorders]. ---
48  2014 [Significance of circulating immune complexes (CIC) in the diagnosis of infections with Borrelia burgdorferi]. ---
49  2013 Clinical features of a new disease concept, IgG4-related thyroiditis. AIP, beta2-MG, CT, Ig, Ig4-RD, TSH
50  2013 [Analysis of occurrence atypical proteins in the serum at smoking and non-smoking cigarettes patients with lung cancer]. ---
51  2013 [The humoral immunity changes in experimental cranio-cerebral trauma, concurrent with diabetes mellitus]. CCT, DM
52  2012 Carbohydrate-rich high-molecular-mass antigens are strongly recognized during experimental Histoplasma capsulatum infection. ---
53  2012 Circulating Immune Complex Levels are Associated with Disease Severity and Seasonality in Children with Malaria from Mali. ---
54  2012 Expression and significance of leukocyte membrane cofactor protein transcript in systemic lupus erythematosus. MCP, SLE
55  2012 Factors associated with the loss of response to infliximab in patients with Crohn's disease. ANA, CD, CDAI, GMA, IFX, LOR, sIL-2R
56  2012 Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy. OSMF, PEG, SCC
57  2012 [Circulating immune complexes, heat shock proteins in the serum of smoking allergy sufferers--preliminary results]. HSP
58  2012 [Immunological disorders and cytokine profile in systemic and localized sclerosis]. SS, LS
59  2012 [The influence of ozone therapy to some immunological parameters in patients with generalized peritonitis]. GP, MPI, OT
60  2012 [Unusual forms of persistence of Mycoplasma hominis in organism of infected humans]. ---
61  2011 Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection. RF, VL
62  2011 Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance. anti-HBs, HBsAg, HBV
63  2011 Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia. CR1
64  2011 IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. Gal, IgAN, MC
65  2011 Polymorphisms of CD16A and CD32 Fcgamma receptors and circulating immune complexes in Meniere's disease: a case-control study. CATT, MD, SNPs
66  2011 Systemic adverse events following rituximab therapy in patients with Graves' disease. GD, RTX
67  2011 [Estimation of the level of endogenous intoxication in septic infants]. EI, LII
68  2011 [Progressive increase of serum circulating immune complexes and its significance in patients during the progression from chronic hepatitis B to hepatocellular carcinoma]. HCC
69  2010 Anti-polymorphonuclear neutrophil antibodies in patients with leukopenia or neutropenia. GIFT, HNA, IND, LAGT, NP, PMN, TNF-alpha
70  2010 Borna disease virus (BDV) circulating immunocomplex positivity in addicted patients in the Czech Republic: a prospective cohort analysis. BDV, GGT
71  2009 Borna disease virus circulating immunocomplex positivity and psychopathology in psychiatric patients in the Czech Republic. BDV
72  2009 Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio. ---
73  2009 [Antituberculosis humoral immunity in patients with tuberculosis, HIV infection concurrent with tuberculoses]. EIA, TB
74  2009 [Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjogren's syndrome]. IgG, slgA, SP, SS, USFR
75  2009 [Comparative characteristics of immunological tests in differentiation of systemic and cutaneous forms of lupus erythematosus]. ILE, SLE
76  2009 [Effects of Astragalus heteropolysaccharides on erythrocyte immune adherence function of mice with adjuvant-induced arthritis]. AA, AHPS, CR1, IC, P-S, TG
77  2009 [Immune status in hiv-infected patients with candidosis]. IRI
78  2009 [Neutrophilic intracellular metabolic changes and fatal outcome in coronary heart disease]. CHD
79  2009 [Preservation of antigens and DNA of urogenital mycoplasmas in circulating immune complexes]. ---
80  2008 Altered systemic serologic parameters in patients with silicone mammary implants. ANA, APA, cANCA, CL-Ab, RF, sICAM-1, SMIs
81  2008 Effect of Ramadan on neutrophil's respiratory burst (innate immunity) and circulating immune complex. CL
82  2008 Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events. cBSA, Igs, MN
83  2008 Immunogenicity of advanced glycation end products in diabetic patients and in nephropathic non-diabetic patients on hemodialysis or after renal transplantation. Ab-AGE, AGE, ELISA, nox-AGE, ox-AGE
84  2008 Immunological and biochemical markers in oral carcinogenesis: the public health perspective. ---
85  2008 [Clinico-immunological disorders in patients with ischemic heart disease combined with metabolic syndrome and modulating effect of nebivolol for their correction]. CL, DM, IHD, MS, TNF-alpha
86  2008 [Clinicoimmunological disorders in patients with postinfarction left ventricular remodeling and chronic cardiac failure]. CCF, CL, EF, IHD, PLVR
87  2008 [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice]. ANA, DIF, HAX-1, IFN, PAS
88  2008 [The occurrence of anticardiolipin antibodies bound in circulating immunological complexes in sera of patients suffering from juvenile lupus erythematosus and juvenile idiopathic arthritis]. ACA, APA, JIA, JSLE
89  2007 Antibody response in pulmonary tuberculosis against recombinant 27kDa (MPT51, Rv3803c) protein of Mycobacterium tuberculosis. ELISA, PEG
90  2007 Circulating immune complex during Ramadan. ---
91  2007 Circulating Immune complexes (CIC) as marker for disease progress in oral cancer. ---
92  2007 Decreased T cell response to mitogen and increased anti-cytoplasmic antibody in drug-free schizophrenic patients. ACA, ANA, PHA
93  2007 Detection of free elastin-derived peptides among diabetic children. EDP
94  2007 Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of IgG4. SLE, SS
95  2007 Evaluation of follow-up of therapy with fenbendazole incorporated into stabilized liposomes and immunomodulator glucan in mice infected with Toxocara canis larvae. p.i
96  2007 Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus. mAb, Mo, SLE
97  2007 Non-specific immunological determinations in Meniere's disease: any role in clinical practice? ESR
98  2006 Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial. OSMF, SCC, Se
99  2006 Clinical value of specific detection of immune complex-bound antibodies in pulmonary tuberculosis. ---
100  2006 Immunoadsorption in pemphigus. Dsg, IA